Hypertension Drug Market Explores New Growth Opportunities by Leading Manufacturers: Actelion, Novartis, Pfizer, Sanofi
According to the Centers for Disease Control and Prevention (CDC), hypertension was the leading cause of death for more than 410,000 Americans in 2014. Hypertension is a long-term disease and, therefore, it requires the daily administration of antihypertensive drugs, which are expected to lead to the hypertension market. In addition, R & D activities related to hypertension medicines are expected to present new opportunities during the prognosis period.
Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2647?utm_source=openpr_ss
However, the expiration of patents for antihypertensive drugs, such as Benicar and Diovan, can hamper the growth of the market. In addition, strict government regulations, the adverse effects of these medications and the high cost of medical care leading to undiagnosed hypertension restrict the market.
The market is segmented according to type and geography. Depending on the type, the market is divided into diuretics, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, alpha-beta blockers, angiotensin II receptor blockers, aldosterone antagonists, calcium channel blockers, Renin inhibitors, alpha blockers, central action agents. , vasodilators, and others. Geographically, it is analyzed in North America, Europe, Asia-Pacific and LAMEA.
Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2647?utm_source=openpr_ss
Major Market Players:
• Actelion Ltd.
• Novartis AG
• Pfizer Inc.
• Johnson &Johnson Ltd.
• Sanofi SA
• Lupin Limited
Key Benefits of Hypertension Drug Market:
• The study provides an in-depth analysis of the global Alprazolam powder market, with current trends and future estimates to elucidate investment pockets.
• It provides a comprehensive analysis of the factors that drive and restrict market growth.
• The report presents a quantitative analysis to help stakeholders capitalize on prevailing market opportunities.
• The extensive analysis of different segments facilitates the understanding of various products in the market.
• Key players are shaping up and their strategies are thoroughly analyzed to predict the competitive perspective of the market.
Browse More Details of Report @ https://www.alliedmarketresearch.com/hypertension-drug-market?utm_source=openpr_ss
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hypertension Drug Market Explores New Growth Opportunities by Leading Manufacturers: Actelion, Novartis, Pfizer, Sanofi here
News-ID: 1586775 • Views: 409
More Releases from Allied Market Research
North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently
More Releases for Hypertension
4th International Conference on Hypertension & Healthcare
We take the privilege of hosting International Hypertension meetings worldwide and very excited to expand to 4th International Conference on Hypertension & Healthcare to be held in beautiful city Zurich, Switzerland in the month of September 10th- 11th, 2018. As with the three meetings, the Hypertension 2018 will be on high-level updates, debates, hot topics and future research directions in the areas of Cardiology, cardiovascular diseases, Pulmonary Hypertension, Hypertension &
Global Pulmonary Arterial Hypertension Market to 2024
Global Pulmonary Arterial Hypertension (PAH) market was valued at $5.0bn in 2015 and is forecast to grow at a modest 6.0% CAGR between 2015 and 2024, to result in 2024 global sales of $9.0bn. PAH is broadly split into two classes, primary or secondary. Primary pulmonary hypertension (PPH) refers to pulmonary hypertension occurring without an identifiable cause. Secondary pulmonary arterial hypertension (PAH) occurs in association with some other identifiable medical condition.
Hypertension: Often unnoticed, always a risk
Vital mushrooms provide a valuable contribution in the prevention and therapy of hypertension Hypertension is considered one of the greatest health problems of the modern age. In the United Kingdom alone, according to data from the NHS, about 12,5 million people - almost every fourth - are affected. The great danger: Although hypertension can cause further serious diseases, many sufferers do not suspect their hypertension. They feel well and have
H2 2017 Pulmonary Arterial Hypertension - Pipeline Review
"The Report Pulmonary Arterial Hypertension - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Pipeline Review, H2 2017, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline landscape. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the
Ocular Hypertension - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H1 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017. High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension